Jasper Ridge Partners, L.P. - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 277 filers reported holding CLOVIS ONCOLOGY INC in Q2 2017. The put-call ratio across all filers is 0.51 and the average weighting 0.5%.

Quarter-by-quarter ownership
Jasper Ridge Partners, L.P. ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q3 2018$270,000
-35.4%
9,1840.0%0.02%
-54.5%
Q2 2018$418,000
-13.8%
9,1840.0%0.03%
+13.8%
Q1 2018$485,000
-22.4%
9,1840.0%0.03%
-29.3%
Q4 2017$625,000
-17.4%
9,1840.0%0.04%
+7.9%
Q3 2017$757,000
-12.0%
9,1840.0%0.04%
-17.4%
Q2 2017$860,000
+47.0%
9,1840.0%0.05%
+15.0%
Q1 2017$585,000
+186.8%
9,184
+100.0%
0.04%
+185.7%
Q4 2016$204,000
-51.7%
4,5920.0%0.01%
-54.8%
Q3 2015$422,000
-66.3%
4,592
-67.7%
0.03%
-64.4%
Q2 2015$1,251,000
+224.9%
14,235
+67.6%
0.09%
+222.2%
Q3 2014$385,000
+9.4%
8,4950.0%0.03%
+12.5%
Q2 2014$352,000
-40.1%
8,4950.0%0.02%
-36.8%
Q1 2014$588,000
-31.5%
8,495
-40.3%
0.04%
-29.6%
Q4 2013$858,000
-0.8%
14,2350.0%0.05%0.0%
Q3 2013$865,000
-9.2%
14,2350.0%0.05%
-3.6%
Q2 2013$953,00014,2350.06%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q2 2017
NameSharesValueWeighting ↓
Versant Venture Management, LLC 814,833$45,630,648,00043.63%
EcoR1 Capital, LLC 384,348$21,523,00010.89%
Palo Alto Investors LP 2,102,857$117,760,0006.91%
NEA Management Company, LLC 2,279,781$127,668,0006.19%
Redmile Group, LLC 721,632$40,411,0004.40%
Opaleye Management Inc. 140,000$7,840,0003.96%
CLIFTON PARK CAPITAL MANAGEMENT, LLC 790,555$44,271,0002.63%
SUFFOLK CAPITAL MANAGEMENT LLC 339,327$19,002,0002.31%
PFM Health Sciences, LP 1,725,126$96,607,0002.26%
HARBOURVEST PARTNERS LLC 51,037$2,858,0001.50%
View complete list of CLOVIS ONCOLOGY INC shareholders